Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation

Journal of the American Society of Nephrology

Volumn 21, Issue 5, 2010, Pages 868-875

  Ducloux, Didier ^a,b,c,d,e,f   Courivaud, Cécile ^a,b,c,d,e   Bamoulid, Jamal ^a,b,c,d,e   Vivet, Bérengère ^a,b,c,d,e   Chabroux, Aline ^a,b,c,d,e   Deschamps, Marina ^a,b,c,d   Rebibou, Jean Michel ^a,b,c,d,g   Ferrand, Christophe ^a,b,c,d   Chalopin, Jean Marc ^a,b,c,d,e,f   Tiberghien, Pierre ^a,b,c,d,f   Saas, Philippe ^a,b,c,d,f  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^d IFR 133   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

^f HÔPITAL SAINT JACQUES   (France)

^g DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DEATH; FEMALE; HAZARD RATIO; HUMAN; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

EID: 77952574304     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009090976     Document Type: Article

References (27)

1. Bonnefoy-Berard N, Vincent C, Revillard JP: Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51: 669-673, 1991
2. Rebellato LM, Gross U, Verbanac KM, Thomas M: A comprehensive definition of the major antibody specificities in polyclonal rabbit antilymphocyte globulin. Transplantation 57: 685-694, 1994
3. Preville X, Flacher M, LeMauff B, Beauchard S, Davelu P, Tiollier J, Revillard JP: Mechanisms involved in antithymocyte globulin immunosuppressive activity in a non human primate model. Transplantation 71: 460-468, 2001
4. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N: Induction of Fas(Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 91: 2360-2368, 1998
5. Müller TF, Grebe SO, Neumann MC, Heymanns J, Radsak K, Sprenger H, Lange H: Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 64: 1432-1435, 1997
6. Ducloux D, Carron PL, Racadot E, Rebibou JM, Bresson-Vautrin C, Saint-Hillier Y, Chalopin JM: CD4 lymphocytopenia in long-term renal transplant recipients. Transplant Proc 30: 2859-2860, 1998
7. Ducloux D, Carron PL, Rebibou JM, Aubin F, Fournier V, Bresson-Vautrin C, Blanc D, Humbert P, Chalopin JM: CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 65: 1270-1272, 1998
8. Ducloux D, Carron PL, Motte G, Ab A, Rebibou JM, Bresson-Vautrin C, Tiberghien P, Saint-Hillier Y, Chalopin JM: Lymphocyte subsets and assessment of cancer risk in renal transplant recipients. Transpl Int 15: 393-396, 2002
9. Ducloux D, Challier B, Saas P, Tiberghien P, Chalopin JM: CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 14: 767-772, 2003
10. Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL, Swanson SJ, Mannon RB, Roederer M, Kirk AD: Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 5: 465-474, 2005
11. Neujahr DC, Chen C, Huang X, Markmann JF, Cobbold S, Waldmann H, Sayegh MH, Hancock WW, Turka LA: Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 176: 4632-4639, 2006
12. Monaco AP, Wood ML, Russell PS: Adult thymectomy: Effect on recovery from immunologic depression in mice. Science 149: 432-435, 1965
13. Hochberg EP, Chillemi AC, Wu CJ, Neuberg D, Canning C, Hartman K, Alyea EP, Soiffer RJ, Kalams SA, Ritz J: Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 98: 1116-1121, 2001
14. Clave E, Rocha V, Talvensaari K, Busson M, Douay C, Appert ML, Rabian C, Carmagnat M, Garnier F, Filion A, Socié G, Gluckman E, Charron D, Toubert A: Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 105: 2608-2613, 2005
15. Chen X, Barfield R, Benaim E, Leung W, Knowles J, Lawrence D, Otto M, Shurtleff SA, Neale GA, Behm FG, Turner V, Handgretinger R: Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 105: 886-893, 2005
16. Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H: Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108: 1232-1237, 2003
17. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z: Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12: 178-180, 2006 (Pubitemid 43214743)
18. Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE: Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113: 2301-2312, 2006
19. Gotsman I, Grabie N, Gupta R, Dacosta R, Macconmara M, Lederer J, Sukhova G, Witztum JL, Sharpe AH, Lichtman AH: Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114: 2047-2055, 2006
20. Lewin SR, Heller G, Zhang L Rodrigues E, Skulsky E, van den Brink MR, Small TN, Kernan NA, O'Reilly RJ, Ho DD, Young JW: Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 100: 2235-2242, 2002
21. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B, Roosnek E: Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96: 2299-2303, 2000
22. Hakim FT, Memon SA, Cepeda R Jones EC, Chow CK, Kasten-Sportes C, Odom J, Vance BA, Christensen BL, Mackall CL, Gress RE: Agedependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 115: 930-939, 2005
23. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA: Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695, 1998
24. Noël C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Hazzan M: Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol 20: 1385-1392, 2009
25. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D: Thymoglobulin Induction Study Group: Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 355: 1967-1977, 2006
26. Hakim FT, Gress RT: Immunosenescence: Deficits in adaptive immunity in the elderly. Tissue Antigens 70: 179-189, 2007
27. Larosa F, Marmier C, Robinet E, Ferrand C, Saas P, Deconinck E, Bulabois CE, Rohrlich PS, Ledu K, Helias P, Tiberghien P, Cahn JY: Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation. Bone Marrow Transplant 35: 859-868, 2005